BioSig Technologies PURE EP featured in abstract presentation

BioSig Technologies announcedthat its PURE EP System was featured in an abstract presentation during the 15th Asia Pacific Heart Rhythm Society, APHRS, Scientific Session in Singapore. Results from the randomized study reveal the PURE EP System’s potential to promote shorter procedural times and higher cost savings during catheter ablations. The study enrolled 29 patients with non-paroxysmal AF with post-ablation arrhythmia recurrence. The primary objective was to determine the difference in procedural times when comparing ablations guided by PURE EP’s electrocardiogram visualization to the conventional ECG recording system. Study results demonstrated that the PURE EP System led to a mean procedure time reduction of 11.3 minutes. Given that the mean cost of operating room time is approximately $37 per minute1, the procedural time savings demonstrated by the PURE EP System suggest potential cost savings of approximately $418.10 per procedure. While this suggests that PURE EP might promote shorter procedural times, further studies are underway. "With over 75,000 AF ablations performed in the US each year2 the ability to demonstrate that PURE EP may reduce procedure times resulting in potential healthcare cost savings is a landmark milestone for the overarching value proposition of our technology," said Gray Fleming, Chief Commercialization Officer, BioSig Technologies, Inc. "We believe a hospital can generate a meaningful return on investment in the first year of ownership of a PURE EP(TM) System. Additional studies demonstrating compelling clinical and economic value of the PURE EP System are in motion and we are looking forward to sharing these insights with the EP and healthcare community in the near future."